{"cik":"0001006281","ticker":"PLX","name":"Protalix BioTherapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"NYSE","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-03-18","last_filing_date":"2026-09-09","url":"/sec/cik-0001006281","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0001178913-26-004471","form_type":"4","form_type_family":"insider","doc_date":"2026-09-09","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-09","url_slug":"/sec/cik-0001006281/4/0001178913-26-004471","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001178913-26-004471-index.html"},{"accession_number":"0002075661-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0002075661-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0002075661-26-000002-index.html"},{"accession_number":"0001935668-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001935668-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001935668-26-000002-index.html"},{"accession_number":"0001831558-26-000003","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001831558-26-000003","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001831558-26-000003-index.html"},{"accession_number":"0001781450-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001781450-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001781450-26-000002-index.html"},{"accession_number":"0001742727-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001742727-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001742727-26-000002-index.html"},{"accession_number":"0001614890-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001614890-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001614890-26-000002-index.html"},{"accession_number":"0001454771-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001454771-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001454771-26-000002-index.html"},{"accession_number":"0001385113-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-09-04","title":"4 — Protalix BioTherapeutics, Inc. — 2026-09-04","url_slug":"/sec/cik-0001006281/4/0001385113-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001385113-26-000002-index.html"},{"accession_number":"0001104659-26-094487","form_type":"S-8","form_type_family":"other","doc_date":"2026-08-12","title":"S-8 — Protalix BioTherapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001006281/s-8/0001104659-26-094487","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-094487-index.html"},{"accession_number":"0001104659-26-094433","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-12","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-094433","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-094433-index.html"},{"accession_number":"0001104659-26-094444","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-12","title":"10-Q — Protalix BioTherapeutics, Inc. — 2026-08-12","url_slug":"/sec/cik-0001006281/10-q/0001104659-26-094444","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-094444-index.html"},{"accession_number":"0002012383-26-002863","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-07-29","title":"SCHEDULE 13G — Protalix BioTherapeutics, Inc. — 2026-07-29","url_slug":"/sec/cik-0001006281/schedule-13g/0002012383-26-002863","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0002012383-26-002863-index.html"},{"accession_number":"0001104659-26-077790","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-25","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-077790","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-077790-index.html"},{"accession_number":"0001104659-26-064850","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-21","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-05-21","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-064850","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-064850-index.html"},{"accession_number":"0001104659-26-059749","form_type":"8-K","form_type_family":"current","doc_date":"2026-05-13","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-059749","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-059749-index.html"},{"accession_number":"0001104659-26-059756","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-05-13","title":"10-Q — Protalix BioTherapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001006281/10-q/0001104659-26-059756","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-059756-index.html"},{"accession_number":"0001975896-26-000003","form_type":"3/A","form_type_family":"insider","doc_date":"2026-04-27","title":"3/A — Protalix BioTherapeutics, Inc. — 2026-04-27","url_slug":"/sec/cik-0001006281/3-a/0001975896-26-000003","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001975896-26-000003-index.html"},{"accession_number":"0001426156-26-000006","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-03-30","title":"SCHEDULE 13G/A — Protalix BioTherapeutics, Inc. — 2026-03-30","url_slug":"/sec/cik-0001006281/schedule-13g-a/0001426156-26-000006","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001426156-26-000006-index.html"},{"accession_number":"0001104659-26-029846","form_type":"8-K","form_type_family":"current","doc_date":"2026-03-18","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-03-18","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-029846","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029846-index.html"},{"accession_number":"0001104659-26-029858","form_type":"10-K","form_type_family":"annual","doc_date":"2026-03-18","title":"10-K — Protalix BioTherapeutics, Inc. — 2026-03-18","url_slug":"/sec/cik-0001006281/10-k/0001104659-26-029858","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-029858-index.html"},{"accession_number":"0001104659-26-024975","form_type":"8-K","form_type_family":"current","doc_date":"2026-03-09","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-03-09","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-024975","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-024975-index.html"},{"accession_number":"0001426156-26-000002","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-03-04","title":"SCHEDULE 13G — Protalix BioTherapeutics, Inc. — 2026-03-04","url_slug":"/sec/cik-0001006281/schedule-13g/0001426156-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001426156-26-000002-index.html"},{"accession_number":"0001104659-26-013498","form_type":"8-K","form_type_family":"current","doc_date":"2026-02-11","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-02-11","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-013498","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-013498-index.html"},{"accession_number":"0001104659-26-008410","form_type":"8-K","form_type_family":"current","doc_date":"2026-01-30","title":"8-K — Protalix BioTherapeutics, Inc. — 2026-01-30","url_slug":"/sec/cik-0001006281/8-k/0001104659-26-008410","edgar_url":"https://www.sec.gov/Archives/edgar/data/1006281/0001104659-26-008410-index.html"}],"related_endpoints":{"profile":"/sec/PLX/profile","timeline":"/sec/PLX/timeline","peers":"/sec/PLX/peers","insider_pulse":"/sec/PLX/insider-pulse","insider_summary":"/sec/PLX/insider-summary","insider_transactions":"/sec/PLX/insider-transactions","form144":"/sec/PLX/form144","holdings_as_filer":"/sec/PLX/holdings","financial_facts":"/sec/PLX/financial-facts","derivatives":"/sec/PLX/derivatives","officers":"/sec/PLX/officers","insider_network":"/sec/PLX/insider-network","risk_flags":"/sec/PLX/risk-flags","filings":"/sec/PLX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=PLX"}}